Stock 000661 CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Changchun High-Tech Industry (Group) Co., Ltd.

Equities

000661

CNE0000007J8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
111.4 CNY +1.86% Intraday chart for Changchun High-Tech Industry (Group) Co., Ltd. -5.48% -23.58%
Apr. 19 Changchun High-Tech Industry Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 10 Changchun High-Tech Industries Inc. has Changed its Name to Changchun High-Tech Industry Co., Ltd CI

Business Summary

Changchun High-Tech Industry (Group) Inc. specializes in the manufacturing and marketing of biopharmaceutical products. Products include polyethylene glycol-based recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, lyophilized live varicella vaccines and rabies vaccines for human use.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Pharmaceutical
93.5 %
11,949 94.6 % 13,613 93.5 % +13.93%
Real Estate
6.3 %
644 5.1 % 914 6.3 % +41.88%
Service
0.3 %
34 0.3 % 38 0.3 % +12.45%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.6 %
12,591 99.7 % 14,511 99.6 % +15.25%
Abroad
0.4 %
36 0.3 % 55 0.4 % +52.19%

Managers

Managers TitleAgeSince
Yun Tao Jiang CEO
 Chief Executive Officer 50 14-12-31
Ji Ma CHM
 Chairman 59 17-10-31
Xing Gong Zhu DFI
 Director of Finance/CFO 57 02-12-31
Peng Ye BRD
 Director/Board Member 57 21-06-22
Zhi Gang Wang BRD
 Director/Board Member 52 14-12-28
Si Liu IRC
 Investor Relations Contact 50 11-12-28
De Shen Zhang LAW
 General Counsel 60 00-12-31
Xiu Feng Li PRN
 Corporate Officer/Principal 55 08-07-31

Members of the board

Members of the board TitleAgeSince
Xiu Feng Li PRN
 Corporate Officer/Principal 55 08-07-31
Zhi Gang Wang BRD
 Director/Board Member 52 14-12-28
Ji Ma CHM
 Chairman 59 17-10-31
Yun Tao Jiang CEO
 Chief Executive Officer 50 14-12-31
Xian Chao Zhu BRD
 Director/Board Member 59 19-03-27
Shu Li BRD
 Director/Board Member 52 18-06-25
Yu Zhi Zhang BRD
 Director/Board Member 58 20-04-15
Peng Ye BRD
 Director/Board Member 57 21-06-22
Bing Jie CHM
 Chairman 51 21-12-08
Wei Ming Zhang BRD
 Director/Board Member 47 21-08-13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 404,544,190 279,534,410 ( 69.10 %) 3,815,201 ( 0.9431 %) 69.10 %

Shareholders

NameEquities%Valuation
Changchun New Region State Owned Asset Sub & Admini Commisio
18.97 %
76,256,454 18.97 % 1 268 M ¥
Lei Jin
8.618 %
34,645,705 8.618 % 576 M ¥
China Merchants Fund Management Co., Ltd.
2.640 %
10,614,409 2.640 % 177 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
1.861 %
7,480,605 1.861 % 124 M ¥
Dian Hai Lin
1.845 %
7,416,420 1.845 % 123 M ¥
China Investment Corp. (Investment Management)
1.599 %
6,427,200 1.599 % 107 M ¥
Rongtong Fund Management Co., Ltd.
1.236 %
4,969,341 1.236 % 83 M ¥
Yinhua Fund Management Co., Ltd.
0.9009 %
3,621,661 0.9009 % 60 M ¥
Fullgoal Fund Management Co., Ltd.
0.8990 %
3,614,300 0.8990 % 60 M ¥
Penghua Fund Management Co., Ltd.
0.8960 %
3,602,123 0.8960 % 60 M ¥
NameEquities%Valuation
Zhi Gang Wang
0.5909 %
15,900 0.5909 % 264 412 ¥
Xiu Feng Li
0.5825 %
15,675 0.5825 % 260 670 ¥
Xing Gong Zhu
0.5770 %
15,526 0.5770 % 258 192 ¥
De Shen Zhang
0.4299 %
11,569 0.4299 % 192 389 ¥
Yun Tao Jiang
0.2536 %
6,825 0.2536 % 113 497 ¥

Company contact information

Changchun High & New Technology Industries (Group), Inc.

27/F, Building B Hi-tech Hairong Plaza

130012, Changchun

+86 431 8055 7027

http://www.ccht.jl.cn
address Changchun High-Tech Industry (Group) Co., Ltd.(000661)

Group companies

NameCategory and Sector
CHANGCHUN BCHT BIOTECHNOLOGY CO.
Biotechnology

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Changchun High-Tech Industry (Group) Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
111.4 CNY
Average target price
195.3 CNY
Spread / Average Target
+75.32%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. Stock Changchun High-Tech Industry (Group) Co., Ltd.
-23.58% 6.18B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000661 Stock
  4. Company Changchun High-Tech Industry (Group) Co., Ltd.